IT1255639B - Uso dell'oxatomide come agente antitosse - Google Patents

Uso dell'oxatomide come agente antitosse

Info

Publication number
IT1255639B
IT1255639B ITMI921866A ITMI921866A IT1255639B IT 1255639 B IT1255639 B IT 1255639B IT MI921866 A ITMI921866 A IT MI921866A IT MI921866 A ITMI921866 A IT MI921866A IT 1255639 B IT1255639 B IT 1255639B
Authority
IT
Italy
Prior art keywords
oxatomide
agent
aged
antitussive agent
antitussive
Prior art date
Application number
ITMI921866A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ITMI921866A priority Critical patent/IT1255639B/it
Publication of ITMI921866A0 publication Critical patent/ITMI921866A0/it
Priority to DE69308680T priority patent/DE69308680D1/de
Priority to EP93111736A priority patent/EP0584535B1/en
Priority to AT93111736T priority patent/ATE149837T1/de
Priority to US08/097,676 priority patent/US5422357A/en
Priority to JP5207107A priority patent/JPH06183977A/ja
Publication of ITMI921866A1 publication Critical patent/ITMI921866A1/it
Application granted granted Critical
Publication of IT1255639B publication Critical patent/IT1255639B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)

Abstract

E'descritto l'uso di oxatomide come agente antitosse.
ITMI921866A 1992-07-30 1992-07-30 Uso dell'oxatomide come agente antitosse IT1255639B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI921866A IT1255639B (it) 1992-07-30 1992-07-30 Uso dell'oxatomide come agente antitosse
DE69308680T DE69308680D1 (de) 1992-07-30 1993-07-22 Gebrauch von Oxatomide als Antitussivum
EP93111736A EP0584535B1 (en) 1992-07-30 1993-07-22 Use of oxatomide as antitussive agent
AT93111736T ATE149837T1 (de) 1992-07-30 1993-07-22 Gebrauch von oxatomide als antitussivum
US08/097,676 US5422357A (en) 1992-07-30 1993-07-27 Method of using oxatomide as antitussive agent
JP5207107A JPH06183977A (ja) 1992-07-30 1993-07-29 鎮咳剤としてのオキサトマイドの使用法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921866A IT1255639B (it) 1992-07-30 1992-07-30 Uso dell'oxatomide come agente antitosse

Publications (3)

Publication Number Publication Date
ITMI921866A0 ITMI921866A0 (it) 1992-07-30
ITMI921866A1 ITMI921866A1 (it) 1994-01-30
IT1255639B true IT1255639B (it) 1995-11-09

Family

ID=11363788

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921866A IT1255639B (it) 1992-07-30 1992-07-30 Uso dell'oxatomide come agente antitosse

Country Status (6)

Country Link
US (1) US5422357A (it)
EP (1) EP0584535B1 (it)
JP (1) JPH06183977A (it)
AT (1) ATE149837T1 (it)
DE (1) DE69308680D1 (it)
IT (1) IT1255639B (it)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
WO1992004022A1 (en) * 1990-09-11 1992-03-19 Richardson Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders

Also Published As

Publication number Publication date
EP0584535B1 (en) 1997-03-12
ITMI921866A1 (it) 1994-01-30
EP0584535A1 (en) 1994-03-02
US5422357A (en) 1995-06-06
ATE149837T1 (de) 1997-03-15
DE69308680D1 (de) 1997-04-17
ITMI921866A0 (it) 1992-07-30
JPH06183977A (ja) 1994-07-05

Similar Documents

Publication Publication Date Title
ATE208621T1 (de) Stabilisierung der prostaglandinzusammensetzungen
NL930005I2 (nl) 17 Beta-gesubstitueerde-4-aza-5alfa-androstenonen en gebruik ervan als inhibitoren van 5alfa-reduct ase.
ES2138247T3 (es) Composicion y uso.
IT1230485B (it) Particelle fini di poliorganosilsesquiossano e procedimento per produrre le stesse
FI935671A7 (fi) Hyytelöimisaineita
BR9711586A (pt) Compostos e uso dos mesmo
GR890100008A (el) Παράγωγα ισοκινολίνης, παρασκευή τους και χρήση τους.
FI935670A7 (fi) Ksantaanipohjaisia geeliytysaineita
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
DE68923860D1 (de) Derivate von Alkoholen und Ethern.
IT1240773B (it) Perfezionamento composizioni pozzolaniche.
FI96327B (fi) Ferriittis-perliittisen teräksen käyttö
IT1264965B1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
FI952458A7 (fi) Dimetyylibentsofuraanien ja dimetyylibentsopyraanien käyttö 5-HT3-anta gonisteina
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
FI962481A0 (fi) 4-bentsoyyli-isokatsolit ja niiden käyttö herbisideinä
ES2054881T3 (es) Pantetina como agente inhibidor de la fibrosis hepatica.
DE69026645D1 (de) Verwendung schäumbarer Zusammensetzungen
FI920423A0 (fi) Foerbaettringar i skaeranordning.
NO940190D0 (no) Anvendelse av x-ketoglutarat
DK0532629T3 (da) 1-Piperidinyl-alkanoylarylsulfonamid-derivater
FI944714L (fi) Beta-karboliinien uusi käyttö
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
ITMI921866A1 (it) Uso dell'oxatomide come agente antitosse
MX9703288A (es) Oxazolil- y tiazolilimidazo-benzo- y tienodiacepinas y su uso como medicamentos.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970729